Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
10/05/2000 | WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia |
10/05/2000 | WO2000057837A2 Compositions and methods for effecting the levels of cholesterol |
10/05/2000 | WO2000057707A1 Methods of treating alzheimer's disease and other amyloidoses using hypericum perforatum and derivatives thereof |
10/05/2000 | WO2000032228A3 Peptide-based vaccine for influenza |
10/05/2000 | WO2000031127A3 Protein fragments for use in protein targeting |
10/05/2000 | WO2000029574A3 Inflammation-associated genes |
10/05/2000 | WO2000029433A3 12-25-kda bacterial proteins and their 116-58 kda polymers for use e.g. in anti-tumor vaccines |
10/05/2000 | WO2000028039A3 Identification of senv genotypes |
10/05/2000 | WO2000027880A3 Rantes-derived peptides with anti-hiv activity |
10/05/2000 | WO2000026379A3 Polypeptide mediating cell permeability |
10/05/2000 | WO2000025811A3 Multicomponent meningococcal vaccine |
10/05/2000 | WO2000025804A3 A method for inhibition of phospholamban activity for the treatment of cardiac disease and heart failure |
10/05/2000 | WO2000023088A3 Methods of administering adenoviral vectors |
10/05/2000 | WO2000020638A9 Methods and compositions for the diagnosis and therapy of prostate cancer |
10/05/2000 | WO2000011179A9 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM) |
10/05/2000 | WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies |
10/05/2000 | WO1998041232A3 Compositions for modulating responsiveness to corticosteroids |
10/05/2000 | DE19915178A1 Hepatitis C Virus Zellkultursystem Hepatitis C virus cell culture system |
10/05/2000 | CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx |
10/05/2000 | CA2370441A1 50 human secreted proteins |
10/05/2000 | CA2369458A1 47 human secreted proteins |
10/05/2000 | CA2368927A1 45 human secreted proteins |
10/05/2000 | CA2368790A1 Attenuated dengue-3 virus vaccine |
10/05/2000 | CA2368719A1 50 human secreted proteins |
10/05/2000 | CA2368700A1 49 human secreted proteins |
10/05/2000 | CA2368674A1 Multivalent dengue virus vaccine |
10/05/2000 | CA2368673A1 Attenuated dengue-4 virus vaccine |
10/05/2000 | CA2368489A1 50 human secreted proteins |
10/05/2000 | CA2368302A1 49 human secreted proteins |
10/05/2000 | CA2368233A1 Recombinant neospora antigens and their uses |
10/05/2000 | CA2368014A1 Casb619 involved in colon cancers |
10/05/2000 | CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
10/05/2000 | CA2367424A1 Hookworm platelet inhibitor |
10/05/2000 | CA2366012A1 Methods of treating leukemia |
10/05/2000 | CA2365728A1 Attenuated dengue-1 virus vaccine |
10/05/2000 | CA2365415A1 Adaptation of virus to vertebrate cells |
10/05/2000 | CA2365411A1 Attenuated dengue-2 virus vaccine |
10/05/2000 | CA2363716A1 49 human secreted proteins |
10/05/2000 | CA2329261A1 Susceptibility to psoriasis |
10/05/2000 | CA2329152A1 Peptide vaccine for canine allergy |
10/04/2000 | EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease |
10/04/2000 | EP1040187A2 Human protein kinase and kinase inhibitors |
10/04/2000 | EP1040124A1 Novel abc transporter |
10/04/2000 | EP1040123A2 Human papillomavirus vaccine |
10/04/2000 | EP1039933A2 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS |
10/04/2000 | EP1039931A1 Multivalent recombinant antibodies for treating hrv infections |
10/04/2000 | EP1039930A2 Adjuvanted vaccine formulation |
10/04/2000 | EP1039929A1 Activated t-cells and their uses |
10/04/2000 | EP1039928A1 Intranasal yellow fever vaccination |
10/04/2000 | EP1039927A1 UGC (UPSTREAM GENE OF cdsA) |
10/04/2000 | EP1039926A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
10/04/2000 | EP1039889A1 Immunoglobulin-rich milk, production and use thereof |
10/04/2000 | EP0821583B1 Dna vaccines against rotavirus infections |
10/04/2000 | EP0705109B1 Adjuvants for vaccines against respiratory syncytial virus |
10/04/2000 | EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof |
10/04/2000 | CN1268573A Carrier for expressing Chiense chicken pox virus vaccine strain |
10/04/2000 | CN1268377A Antimatrix metalloprotease monovalent antibody Fab' medicine conjugate and its tumor-resisting action |
10/04/2000 | CN1057128C Sensory nerve antibody and prepn. method therefor |
10/04/2000 | CN1057013C Novel 1 L-2 receptor-specific human immunoglobins |
10/03/2000 | US6127527 Apparatus for the therapeutic use of 213 Bi |
10/03/2000 | US6127522 CRFG-1a, a target and marker for chronic renal failure |
10/03/2000 | US6127345 Utilizing glucose 6-phosphate dehydrogenase gene polypeptide for the protection against infection, particularly bacterial infections |
10/03/2000 | US6127164 Diagnosis using dna which specifically hybridizes under high stringency conditions to genomic dna of type 57 |
10/03/2000 | US6127163 Viral vector which codes exogenous proteins; for use as therapeutic tools in drug delivery |
10/03/2000 | US6127159 Enzymatic polypeptide; for diagnosis and treatment of amyotrophic lateral sclerosis, huntington's disease, parkinson's disease, and alzheimer's disease; for gene therapy |
10/03/2000 | US6127151 Antigenic preparations and the isolation of such preparations |
10/03/2000 | US6127147 Sensor histidine kinase of Staphylococcus Aureus |
10/03/2000 | US6127116 Functional DNA clone for hepatitis C virus (HCV) and uses thereof |
10/03/2000 | US6127113 Testing mammals for microorganismal induced dietetics; obtaining sample, testing for the presence of nucleotide sequences, screening for presence microorganismal nucleotide sequences |
10/03/2000 | US6127112 Avian herpesvirus-A antigen precursor gene |
10/03/2000 | US6126945 Tumor killing effects of enterotoxins, superantigens, and related compounds |
10/03/2000 | US6126938 Administering two identical or different products each containing inducing agent for the immune response, selected from the antigen and, if the antigen is protein in nature, an expression cassette capable of expressing the antigen |
10/03/2000 | US6126937 Clpl polypeptides, polynucleotides encoding clpl polypeptides and methods for producing such polypeptides by recombinant techniques. |
09/30/2000 | CA2267481A1 Critical interdependency: from the role of estrogen on breast cancer to the susceptibility of women towards hiv infection |
09/28/2000 | WO2000057185A1 Method for detecting superantigen activity in a biological sample |
09/28/2000 | WO2000056915A1 Ispa from streptococcus pneumoniae |
09/28/2000 | WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase |
09/28/2000 | WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/28/2000 | WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
09/28/2000 | WO2000056884A1 pksG |
09/28/2000 | WO2000056882A1 48 human secreted proteins |
09/28/2000 | WO2000056881A1 48 human secreted proteins |
09/28/2000 | WO2000056880A1 50 human secreted proteins |
09/28/2000 | WO2000056873A1 mvaA |
09/28/2000 | WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof |
09/28/2000 | WO2000056862A1 Human tumor necrosis factor receptor tr9 |
09/28/2000 | WO2000056774A1 Methods of using bioelastomers |
09/28/2000 | WO2000056773A1 Antibodies specific for cyp1b1 |
09/28/2000 | WO2000056772A1 Human antibodies that bind human il-12 and methods for producing |
09/28/2000 | WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
09/28/2000 | WO2000056770A1 ANTI-p53 ANTIBODIES |
09/28/2000 | WO2000056767A1 46 human secreted proteins |
09/28/2000 | WO2000056754A1 48 human secreted proteins |
09/28/2000 | WO2000056405A2 Human tumor necrosis factor receptor-like 2 |
09/28/2000 | WO2000056365A1 Use of trehalose for stabilising a liquid vaccine |
09/28/2000 | WO2000056363A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
09/28/2000 | WO2000056362A2 Polycationic carbohydrates as immunostimulants in vaccines |
09/28/2000 | WO2000056361A2 Vaccine composition |
09/28/2000 | WO2000056360A2 Vaccine against antigens from bacteriae |
09/28/2000 | WO2000056359A2 Vaccine against streptococcus pneumoniae |